BioNxt Solutions Inc. (BNXTF) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for BioNxt Solutions Inc. (BNXTF).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $0.701

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $85,121,936

Daily Volume: 0

Performance Metrics

1 Week: 20.48%

1 Month: 40.18%

3 Months: 108.7%

6 Months: 90.97%

1 Year: 202.4%

YTD: 110.4%

Details

BioNxt Solutions Inc. engages in research, development, and manufacturing of next generation drug formulations and delivery systems. It provides BNT23001for the treatment of multiple sclerosis; BNT23002 for the treatment of myasthenia gravis; BNT24002 for the treatment of lupus nephritis; BNT24003 for the treatment of rheumatoid arthritis; and BNT24004 for longevity and anti-aging and semaglutide delivery with thin-film technology, as well as transdermal skin-patch. It offers diagnostic screening tests, and new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Selected stocks

AC/DC BATTERY METALS INC (ACDBF)

VALTERRA PLATINUM LTD (AGPPF)

American Rare Earths Ltd. (ARRNF)